RxDoctor Payments Data

Gregory Worley, DPM

Foot & Ankle Surgery · Crestview Hills, KYNPI 1356340939

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (50.6%), education and travel and lodging — rather than concentrated in one kind of arrangement. 41 manufacturers reported payments, led by Arthrex at 38.3% of the total. Reporting peaked in 2022 at $6,478 and has fallen 79.0% since, to $1,358 in 2025.

$11,410in general payments, 2019–2025

Across 204 payments — averaging $55.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Arthrex$4K
  • Legacy Ortho LLC$2K
  • Smith+Nephew$2K
  • Stryker$718
  • Kerecis Limited$433
  • Musculoskeletal Transplant Foundation Inc.$369
  • plus $2K from 35 others

What the payments were for

  • Travel & lodging$2,04218%
  • Food & beverage$5,76851%
  • Education$3,60032%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$11,410 in reported general payments places this provider in the 80th percentile of 141 foot & ankle surgery providers in Kentucky.

See all foot & ankle surgery providers in Kentucky

Medicare billing

Part B allowed, 2024
$249,883
Medicare patients
376
Services billed
15,822

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Doxycycline Monohydrate157$1,374
Fluocinonide-EFluocinonide/Emollient Base29$1,241
Pregabalin50$945
Betamethasone Dipropionate12$580
Gabapentin52$544
Meloxicam17$536
Pentoxifylline41$511
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen64$426
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen55$326
Ketoconazole15$282
Mupirocin31$251
Duloxetine Hcl23$214
Terbinafine Hcl12$156
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav18$135
Promethazine Hcl42$121

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in Crestview Hills

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →